Digital Therapeutics (DTx)
A Proprietary Algorithm-based platform for therapeutic decision making
Biofourmis has 2 patents for its analytics platform
ISO 13485 certified, HIPAA and SOC 2 certified, highest security clearance
Biofourmis platform is FDA 21 CFR 820 compliant
Rethinking Care Management
Imagine being able to use an Artificial Intelligent (AI) platform to predict and prevent serious medical events before they happen. This is not science fiction; this is what drives our mission every day at Biofourmis.
Biovitals™ is a powerful patented AI-based platform for therapeutic decision support. It continuously analyzes data from medical grade wearable sensors and other patient generated data to create unique digital biomarkers reflecting the health status of an individual. These digital biomarkers have been assessed in several real-world studies and have demonstrated the ability to help detect changes in an individual’s health status, much earlier than possible before.
Thanks to the strength of the Biovitals™ platform, Biofourmis is now partnering with leading healthcare providers, payers and pharmaceutical companies around the world to help reduce readmissions, limit ER visits, improve patient outcomes and rethink the way care is managed and reimbursed.
This is real life.Learn More
Personalized disease management through Intelligent Patient Monitoring
To improve patient outcomes and reduce healthcare costs, Biofourmis has developed proven end-to-end solutions that build on the power of the Biovitals™ deep learning platform.
as a service (SaaS) model
Forward-thinking organizations are working with Biofourmis and have deployed the Biovitals™ platform to reduce healthcare costs, improve patient outcomes and demonstrate value.
See how Mayo Clinic, Brigham & Women’s Hospital and others are using Biovitals Platform.Learn More
Learn how leading pharmaceutical companies are demonstrating value and accelerating research.Learn More